Eam Investors, LLC Esperion Therapeutics, Inc. Transaction History

Eam Investors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 03, 2018	SELL	$36.2 - $76.4 $2.38 Million - $5.02 Million	-65,683 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$65.94 - $80.76 $231,515 - $283,548	3,511 Added 5.65%	65,683 $4.75 Million
Q4 2017 May 21, 2018	SELL	$43.47 - $67.43 $1.02 Million - $1.58 Million	-23,376 Reduced 27.33%	62,172 $4.09 Million
Q4 2017 Feb 12, 2018	SELL	$43.47 - $67.43 $319,547 - $495,677	-7,351 Reduced 7.91%	85,548 $5.63 Million
Q3 2017 Nov 08, 2017	BUY	$43.8 - $52.77 $4.07 Million - $4.9 Million	92,899	92,899 $4.66 Million

207

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $168M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.